IL94312A - Stable aqueous solutions of N-8- (diethylaminoethyl) and their preparation - Google Patents

Stable aqueous solutions of N-8- (diethylaminoethyl) and their preparation

Info

Publication number
IL94312A
IL94312A IL9431290A IL9431290A IL94312A IL 94312 A IL94312 A IL 94312A IL 9431290 A IL9431290 A IL 9431290A IL 9431290 A IL9431290 A IL 9431290A IL 94312 A IL94312 A IL 94312A
Authority
IL
Israel
Prior art keywords
acid
diethylaminoethyl
rebeccamycin
water
concentration
Prior art date
Application number
IL9431290A
Other languages
English (en)
Hebrew (he)
Other versions
IL94312A0 (en
Original Assignee
Bristol Myers Squibb Company N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Company N filed Critical Bristol Myers Squibb Company N
Publication of IL94312A0 publication Critical patent/IL94312A0/xx
Publication of IL94312A publication Critical patent/IL94312A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Cephalosporin Compounds (AREA)
IL9431290A 1989-05-10 1990-05-07 Stable aqueous solutions of N-8- (diethylaminoethyl) and their preparation IL94312A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/349,608 US5496809A (en) 1989-05-10 1989-05-10 Stable solutions of rebeccamycin analog

Publications (2)

Publication Number Publication Date
IL94312A0 IL94312A0 (en) 1991-03-10
IL94312A true IL94312A (en) 1994-02-27

Family

ID=23373191

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9431290A IL94312A (en) 1989-05-10 1990-05-07 Stable aqueous solutions of N-8- (diethylaminoethyl) and their preparation

Country Status (25)

Country Link
US (1) US5496809A (fi)
EP (1) EP0397147B1 (fi)
JP (1) JPH0643437B2 (fi)
KR (1) KR920004098B1 (fi)
CN (1) CN1054510C (fi)
AT (1) ATE117313T1 (fi)
AU (1) AU618896B2 (fi)
CA (1) CA2015632C (fi)
CZ (1) CZ283416B6 (fi)
DE (1) DE69016087T2 (fi)
DK (1) DK0397147T3 (fi)
EG (1) EG19218A (fi)
ES (1) ES2066902T3 (fi)
FI (1) FI95777C (fi)
GR (1) GR3015714T3 (fi)
HK (1) HK1005033A1 (fi)
HU (1) HU206627B (fi)
IE (1) IE66515B1 (fi)
IL (1) IL94312A (fi)
NO (1) NO176390C (fi)
PT (1) PT93991B (fi)
RU (1) RU2053766C1 (fi)
TW (1) TW202390B (fi)
YU (1) YU90490A (fi)
ZA (1) ZA903535B (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2130836A1 (en) * 1992-03-20 1993-09-30 Martin J. Slater Further indole derivatives with antiviral activity
US5968961A (en) * 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
AU5103898A (en) * 1996-11-05 1998-05-29 Alcon Laboratories, Inc. Polyhydroxy monocarboxylic and dicarboxylic acids and their lactones in ophthalmic compositions
US20040048012A1 (en) * 1996-11-18 2004-03-11 Weder Donald E. Polymeric materials having a matte finish on a surface thereof
CA2241609C (en) * 1997-06-26 2009-08-25 Southpac Trust International, Inc. Polymeric material having a cloth-like appearance
CN100344285C (zh) * 2005-02-03 2007-10-24 宋艳 多潘立酮水溶性制剂及其制备方法
JP4822151B2 (ja) * 2005-02-14 2011-11-24 山本光学株式会社 眼鏡保持バンドおよびその保持バンド付き眼鏡

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
US4808613A (en) * 1986-11-21 1989-02-28 Bristol-Myers Company Rebeccamycin derivative containing pharmaceutical composition

Also Published As

Publication number Publication date
EP0397147A2 (en) 1990-11-14
JPH0643437B2 (ja) 1994-06-08
AU5482390A (en) 1990-11-15
AU618896B2 (en) 1992-01-09
ATE117313T1 (de) 1995-02-15
TW202390B (fi) 1993-03-21
HU206627B (en) 1992-12-28
KR920004098B1 (ko) 1992-05-25
HUT54053A (en) 1991-01-28
FI95777B (fi) 1995-12-15
KR900017596A (ko) 1990-12-19
HK1005033A1 (en) 1998-12-18
EG19218A (en) 1994-10-30
CN1054510C (zh) 2000-07-19
NO902048L (no) 1990-11-12
HU902989D0 (en) 1990-09-28
IE901687L (en) 1990-11-10
NO902048D0 (no) 1990-05-09
ES2066902T3 (es) 1995-03-16
IE66515B1 (en) 1996-01-10
ZA903535B (en) 1991-01-30
CA2015632A1 (en) 1990-11-10
DK0397147T3 (da) 1995-03-20
FI902276A0 (fi) 1990-05-07
NO176390C (no) 1995-03-29
CZ225590A3 (en) 1997-12-17
PT93991B (pt) 1996-11-29
RU2053766C1 (ru) 1996-02-10
CZ283416B6 (cs) 1998-04-15
CA2015632C (en) 1998-01-27
EP0397147B1 (en) 1995-01-18
IL94312A0 (en) 1991-03-10
DE69016087T2 (de) 1995-05-24
EP0397147A3 (en) 1991-06-12
GR3015714T3 (en) 1995-07-31
US5496809A (en) 1996-03-05
PT93991A (pt) 1991-02-08
CN1047204A (zh) 1990-11-28
YU90490A (en) 1991-10-31
DE69016087D1 (de) 1995-03-02
JPH0317094A (ja) 1991-01-25
FI95777C (fi) 1996-03-25
NO176390B (no) 1994-12-19

Similar Documents

Publication Publication Date Title
AU2002352105B2 (en) Platinum derivative pharmaceutical formulations
JPS6191116A (ja) 安定化された注射用ピロキシカム液剤
BR112015012460B1 (pt) Formulação estabilizada de pemetrexede
US6686365B2 (en) Pharmaceutical composition
ES2256034T3 (es) Soluciones farmaceuticas de levosimendano.
WO2016166653A1 (en) Stable liquid pharmaceutical compositions of bortezomib
EP1265612A1 (en) Pharmaceutical composition comprising pemetrexed together with monothioglycerol, l-cystein or thioglycolic acid
US5496809A (en) Stable solutions of rebeccamycin analog
NL8102362A (nl) Farmaceutische antitumor-preparaat; werkwijze voor de bereiding daarvan.
US4889862A (en) Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
EP0212853A2 (en) Parenteral phenytoin compositions
EA039525B1 (ru) Фосфаплатиновые жидкие составы
KR20030068541A (ko) 산의 함량이 작고 저장 중에 안정한 시프로플록사신 주입물
CA3137265A1 (en) A stable, ready to use aqueous pharmaceutical composition of pemetrexed
US5684009A (en) Parenteral solutions containing 7-halo-1,2,3,4-tetrahydro-3-aryl-6-quinazoline sulfonamides
US4663458A (en) Water soluble salt composition of m-AMSA
RU1837878C (ru) Способ получени противоопухолевого средства на основе производного хинолинкарбоновой кислоты
WO2023237485A1 (en) Stable lyophilisates comprising 5,10-methylene-(6r)-tetrahydrofolic acid
CN117462488A (zh) 含有右旋布洛芬的改善了稳定性的注射用制剂及包含其的注射用药物容器
EA045403B1 (ru) Лиофилизированная композиция, содержащая соединение бензоазепина

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees